Renal Tubular Acidosis
📧 Sign up to get email alerts when something new happens for Renal Tubular Acidosis.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-04-09EMA Authorised: Sibnayal (potassium citrate monohydrated;potassium hydrogen carbonate) — Advicenne S.A.
The EMA authorised Sibnayal (potassium citrate monohydrated and potassium hydrogen carbonate) for renal tubular acidosis–related acidosis. T…
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Association of Renal-tubular Acidosis in Children With Cow Milk Protein Allergy
This clinical trial update reports on the association between renal tubular acidosis and cow milk protein allergy in children.
-
FDA approval · 2024-05-30FDA Approved: POTASSIUM CITRATE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Potassium Citrate from Rising Pharma Holdings, Inc., under ANDA077440.
-
CLINICAL_TRIALS research · 2017-11-28Clinical Trial Update: Use of Sodium Bicarbonate in Patients Treated With Topiramate [NA]
Clinical trial update examining the use of sodium bicarbonate in patients treated with topiramate, in the context of epilepsy and metabolic …
-
CLINICAL_TRIALS research · 2017-09-01Clinical Trial Update: Incidence of Renal Tubular Acidosis in Nephrology Unit in Assiut University Childern Hospital
A ClinicalTrials.gov entry from Assiut University describes an ongoing study to determine the incidence of renal tubular acidosis in pediatr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2015-03-18Clinical Trial Update: Renal Tubular Acidosis is Highly Prevalent in Critically Ill Patients
A completed clinical trial examining the prevalence of renal tubular acidosis in critically ill patients.
-
CLINICAL_TRIALS trial_result · 2012-05-30Clinical Trial Update: Renal Tubular Acidosis in Incident Renal Transplant Recipients
Clinical trial update about renal tubular acidosis in incident renal transplant recipients; the current status of the study is unknown.